Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a randomized, double-masked environmental study-Reference-Cited by-同舟云学术

Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a randomized, double-masked environmental study

Published:2004-08 Issue:8 Volume:26 Page:1237-1248
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Abelson Mark B.,Gomes Paul J.,Vogelson Cullen T.,Pasquine Terri A.,Gross Robert D.,Turner F. Darell,Wells David T.,Bergamini Michael V.W.,Robertson Stella M.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference21 articles.

1. Ocular allergic disease: Mechanisms, disease sub-types, treatment;Abelson;The Ocular Surface,2003

2. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases;Sharif;J Pharmacol Exp Ther,1996

3. The in vitro and in vivo ocular pharmacology of olopatadine (AL4943A), an effective anti-allergic/antihistaminic agent;Yanni;J Ocul Pharmacol Ther,1996

4. Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs;Yanni;Arch Ophthalmol,1999

5. Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells;Yanni;Ann Allergy Asthma Immunol,1997

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TFOS Lifestyle: Impact of elective medications and procedures on the ocular surface;The Ocular Surface;2023-07

2. Reproxalap Activity and Estimation of Clinically Relevant Thresholds for Ocular Itching and Redness in a Randomized Allergic Conjunctivitis Field Trial;Ophthalmology and Therapy;2022-05-18

3. Reproxalap Improves Signs and Symptoms of Allergic Conjunctivitis in an Allergen Chamber: A Real-World Model of Allergen Exposure;Clinical Ophthalmology;2022-01

4. Etiology and pharmacotherapy of ocular surface allergic diseases;Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics;2022

5. Receptors, ion channels, and signal transduction pathways as targets for drug intervention to mitigate ocular diseases;Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics;2022